1. Rasooly, Danielle, Peloso, Gina M, Pereira, Alexandre C, Joseph, Jacob, Casas, Juan P. 2023. Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure. In Nature communications, 14, 3826. doi:10.1038/s41467-023-39253-3. https://pubmed.ncbi.nlm.nih.gov/37429843/
2. Crowder, Mark K, Shrestha, Shristi, Cartailler, Jean-Philippe, Collins, Sheila. . Protein kinase D1 (Prkd1) deletion in brown adipose tissue leads to altered myogenic gene expression after cold exposure, while thermogenesis remains intact. In Physiological reports, 11, e15576. doi:10.14814/phy2.15576. https://pubmed.ncbi.nlm.nih.gov/36807778/
3. Döppler, Heike, Panayiotou, Richard, Reid, Elizabeth M, Bastea, Ligia, Storz, Peter. 2016. The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer. In Scientific reports, 6, 33758. doi:10.1038/srep33758. https://pubmed.ncbi.nlm.nih.gov/27649783/
4. Nickkholgh, Bita, Sittadjody, Sivanandane, Rothberg, Michael B, Hawkins, Gregory A, Balaji, K C. 2017. Beta-catenin represses protein kinase D1 gene expression by non-canonical pathway through MYC/MAX transcription complex in prostate cancer. In Oncotarget, 8, 78811-78824. doi:10.18632/oncotarget.20229. https://pubmed.ncbi.nlm.nih.gov/29108267/
5. Leduc, Fiona, Smol, Thomas, Catteau, Benoit, Boute, Odile, Petit, Florence. 2024. PRKD1-related telangiectasia-ectodermal dysplasia-brachydactyly-cardiac anomaly syndrome: Case report and review of the literature. In European journal of medical genetics, 69, 104942. doi:10.1016/j.ejmg.2024.104942. https://pubmed.ncbi.nlm.nih.gov/38677542/
智鼠故事 
